Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Livia Donzelli
Observed name:
Donzelli L.
Institution:
Sapienza University of Rome
Observed institutions:
Policlinico Umberto I,
Sapienza University of Rome
ORCID:
0000-0002-6926-3648
Observed ORCID:
0000-0002-6926-3648
OpenAlex ID:
A5088338597
Primary mediastinal large B-cell Lymphoma: Biological features, clinical characteristics and current treatment strategies
2025
·
Livia Donzelli
, Alice Di Rocco
, et al.
·
Cancer Treatment Reviews
·
15
Reduced transmission of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae (KPC-KP) in patients with haematological malignancies hospitalized in an Italian hospital during the COVID-19 pandemic
2021
·
Alessandra Micozzi
, Giovanni Manfredi Assanto
, et al.
·
JAC-Antimicrobial Resistance
·
15
PDF
Fostamatinib combined with TPO‐RAs or steroids as a bridge to monotherapy or as time‐limited continuous treatment in relapsed chronic ITP : A single‐centre case series
2024
·
Mauro Passucci
, Alessandro Laganà
, et al.
·
British Journal of Haematology
·
7
Lymphocyte recovery after bendamustine therapy in patients with mantle cell lymphoma. Results of a retrospective analysis and prognostic impact in the CAR-T era
2024
·
Livia Donzelli
, M. Antonacci
, et al.
·
Annals of Hematology
·
6
Secondary prophylaxis of venous thromboembolism (VTE) with low dose apixaban or rivaroxaban: results from a patient population with more than 2 years of median follow-up
2024
·
Alessandro Laganà
, Giovanni Manfredi Assanto
, et al.
·
Mediterranean Journal of Hematology and Infectious Diseases
·
6
PDF
Polatuzumab vedotin–containing regimens as bridge to CART: analysis from the CART-SIE study
2026
·
Giulia Gabrielli
, Beatrice Casadei
, et al.
·
Blood Advances
·
4
PDF
Managing Treatment‐Emergent Immune Effector Cell‐Associated Hemophagocytic Lymphohistiocytosis‐Like Syndrome Following CAR‐T Cell Therapy: A Case‐Based Review of the use of Emapalumab
2025
·
Livia Donzelli
, Veronica Zullino
, et al.
·
Hematological Oncology
·
4
PDF
Immunoterapia cellulare CAR-T nella recidiva precoce post-chemio-immunoterapia di induzione
2026
·
Livia Donzelli
, Alice Di Rocco
·
Recenti Progressi in Medicina
·
2
PDF
Outcomes of CAR T-Cell Therapy in transformed indolent Non-Hodgkin Lymphomas and de novo DLBCL: A comparative analysis from the Italian CAR T-SIE study
2026
·
Fabbri N.
, Casadei B.
, et al.
·
Institutional Research Information System (University of Udine)
·
2
Bing-Neel syndrome coexisting with oligodendroglioma
2022
·
Livia Donzelli
, Clara Minotti
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
1
Differential Immune Dynamics in Large B-Cell Lymphoma Patients Treated With Axi-Cel and Tisa-Cel Car-T Cell Products
2026
·
Giulia Radice
, Nadia Peragine
, et al.
·
Research Square
PDF
Efficacy and Safety of Anti-cd19 Car T-cell Therapy in Secondary Cns Lymphomas Refractory to High-dose Methotrexate-based Treatment
2026
·
Piera Angelillo
, Edoardo Campodonico
, et al.
·
Blood Immunology & Cellular Therapy
PDF
Primary mediastinal B-cell lymphoma: a nationwide real-life retrospective study of first-line treatment approaches in Italy
2026
·
Emilio Iannitto
, Livia Donzelli
, et al.
·
Haematologica
PDF
Venous Thromboembolism in Hematologic Malignancies: Incidence, Risk Factors, and the Role of Direct Oral Anticoagulants
2026
·
Mario Biglietto
, Silvia Sorella
, et al.
·
European Journal Of Haematology
Real-world patient-reported symptomatic adverse events and concordance with physician assessments after CAR T-cell therapy in patients with aggressive B-cell lymphomas: a prospective study
2026
·
Fabio Efficace
, Pier Luigi Zinzani
, et al.
·
The Lancet Haematology
Occult hepatitis B virus infection status is not associated with impaired efficacy of anti‐CD19 CAR‐T‐cell therapy for lymphoma and shows a distinct immune toxicity profile: Results from the CART‐SIE study
2026
·
Nicola Polverelli
, Annalisa Chiappella
, et al.
·
HemaSphere
Anti-CD19 chimeric antigen receptor T-cells therapy (CAR-T) is effective in secondary cns lymphoma (SCNSL) refractory to high-dose methotrexate (HDMTX)-based chemotherapy
2025
·
Piera Angelillo
, Edoardo Campodonico
, et al.
·
Blood
PDF
Show more works
View as search
Works count:
17
Citation count:
62
H-index:
5
I10-index:
2
Year
Topic
Type